Expectations of serious adverse events at the end of life of patients with acute myeloid leukemia who receive salvage therapy

Marylou Cardenas-Turanzas, Farhad Ravandi-Kashani, Jorge E. Cortes, Elias Jabbour, Stefan Faderl, Sherry A. Pierce, Hagop Kantarjian

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Expectations of serious adverse events at the end of life of patients with acute myeloid leukemia who receive salvage therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences